12 January 2021 A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial). View PDF
Recent News 2020 NCUK Research Grant Winner announced at UKINETS 18th National Conference Online COVID-19 and NETs – an update UKINETS Annual Conference – Monday 30th November – Thursday 3rd December NETs for Newcomers – An introduction to NET Medicine – POSTPONED AGITG 23rd Annual Scientific Meeting – 12-15 October 2021
Sign up for our newsletterSign-up for our email newsletter. Simply give us your email address in the box below to sign-up.Email
